Document is current
Any future updates will be listed below
-
Authors
Elias, Kevin
Smyczynska, Urszula https://orcid.org/0000-0003-1399-457X
Stawiski, Konrad
Nowicka, Zuzanna https://orcid.org/0000-0001-7814-5830
Webber, James
Kaplan, Jakub
Landen, Charles
Lubinski, Jan
Mukhopadhyay, Asima
Chakraborty, Dona
Connolly, Denise C.
Symecko, Heather
Domchek, Susan M. https://orcid.org/0000-0002-5914-7272
Garber, Judy E.
Konstantinopoulos, Panagiotis https://orcid.org/0000-0002-1032-1479
Fendler, Wojciech https://orcid.org/0000-0002-5083-9168
Chowdhury, Dipanjan https://orcid.org/0000-0001-5645-3752
- License Information
-
More Information
Article History
Received: 9 November 2022
Accepted: 19 May 2023
First Online: 8 June 2023
Competing interests
: K.E., W.F., K.S., and Di.C. are co-inventors of patent US201762444085P/EP3565903A1 (title “Circulating microrna signatures for ovarian cancer”), which relates to the use of circulating miRNAs for ovarian cancer diagnosis. Dr. Elias, Dr. Fendler, and Dr. Chowdhury acknowledge research funding from Aspira Women’s Health. K.E. reports research funding from Abcam, Inc. The remaining authors declare no competing interests.
